Badgley Phelps Wealth Managers, LLC Gilead Sciences, Inc. Transaction History
Badgley Phelps Wealth Managers, LLC
- $4.21 Billion
- Q4 2024
A detailed history of Badgley Phelps Wealth Managers, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Badgley Phelps Wealth Managers, LLC holds 122,328 shares of GILD stock, worth $14.4 Million. This represents 0.27% of its overall portfolio holdings.
Number of Shares
122,328
Previous 123,628
1.05%
Holding current value
$14.4 Million
Previous $10.4 Million
9.04%
% of portfolio
0.27%
Previous 0.24%
Shares
13 transactions
Others Institutions Holding GILD
# of Institutions
2,099Shares Held
1.02BCall Options Held
8.73MPut Options Held
9.63M-
Black Rock Inc. New York, NY121MShares$14.2 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$13.6 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$8.42 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$7.09 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.8 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $147B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...